| REVIEW ARTICLE |
|
| Year : 2021 | Volume
: 6
| Issue : 3 | Page : 88-90 |
|
|
Liver: Could it lead us to a promised land to deflame the brain?
Ho Jun Yun, Yuchuan Ding
Department of Neurosurgery, Wayne State University School of Medicine, Detroit, MI, USA
Correspondence Address:
Ho Jun Yun
Department of Neurosurgery, Wayne State University School of Medicine, 540 E, Canfield, Detroit 48201, MI
USA
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/ed.ed_20_21
|
|
|
Ischemic stroke occurs with disruption of blood perfusion to the brain. Damages from ischemia result in inflammation of the brain cells. Biologics and immunomodulators have been developed to mitigate neuroinflammation after ischemic stroke. Several druggable targets have been identified, including microglia/macrophages, receptors of the complement pathway, inhibition of tumor necrosis factor-ɑ, and others. However, the efficacy of the immunomodulators is in their infant stage largely due to our incomplete understanding of neuroinflammation. Hypothermia has been utilized to alleviate systemic inflammation though its negative effects have been reported. The roles of the liver in systemic inflammation and its association to ischemic stroke are fairly well-known. Local hypothermic induction to the liver may be a desirable treatment option for ischemic stroke while minimizing the systemic side effects of hypothermia. In this mini-review, we briefly summarize the current understanding of the involvement of active inflammatory response in ischemic stroke and the associated organs, particularly the liver.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
![[JOURNAL_FULL_NAME]](images/logo.gif){kind=logo}
